KemPharm, Inc.
(NASDAQ : KMPH)

( )
KMPH After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
ICPTIntercept Pharmaceuticals, Inc.
-15.77%99.0318.6%$124.68m
AMRNAmarin Corporation Plc Sponsored ADR
-1.94%17.202.0%$108.63m
SAGESAGE Therapeutics, Inc.
-3.46%147.669.5%$76.64m
JAZZJazz Pharmaceuticals Plc
-0.16%126.782.2%$73.19m
PRGOPerrigo Co. Plc
-1.23%48.946.8%$62.45m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-2.86%145.886.3%$59.61m
CTLTCatalent Inc
1.30%42.792.4%$43.64m
PTLAPortola Pharmaceuticals, Inc.
-4.41%29.957.7%$42.51m
ICLRICON Plc
0.44%145.924.1%$35.01m
UTHRUnited Therapeutics Corporation
-0.74%117.8914.4%$30.71m
CORTCorcept Therapeutics Incorporated.
-1.31%11.325.5%$29.90m
HZNPHorizon Pharma plc
-4.99%21.547.4%$29.89m
MDCOMedicines Company
-2.69%23.8921.8%$27.18m
AERIAerie Pharmaceuticals, Inc.
-2.92%39.616.9%$26.58m
MNKMallinckrodt Plc
-3.24%21.2221.1%$25.16m

Company Profile

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Coralville, IA.